TheAdvocacy Network (BCAN) is pleased to award three Young Investigator Awards to support research. The award winners, Sunny Guin, PhD, Ryoichi Saito, MD, PhD, and Dmitriy Zamarin, MD, PhD, will each receive a two-year grant totaling $100,000 to support their research efforts. The recipients were selected by BCAN’s Scientific Review Group from a field of 32 applicants from 27 institutions.
The awards coincide withAwareness Month, a national effort led by BCAN to provide public awareness about this deadly disease and recognize the 500,000 people living with in the United States.
First launched in 2013, BCAN’s Young Investigator Awards seek to fund those researchers who may be working in basic, translational, clinical, epidemiologic, bioengineering or any other scientific or research field, but are also working in a research environment capable of supporting transformationalresearch. Since inception, BCAN has raised over $1 million to support its Young Investigator Awards program.
“We are honored to make this investment inresearch to support young investigators. We are hopeful that these young investigators will break new ground and help save lives,” stated Diane Zipursky Quale, President and Co-Founder. “We are grateful for the generosity of the JPB Foundation and our other donors who make our research efforts possible.”
The BCAN YOUNG INVESTIGATOR AWARD was granted to Sunny Guin, PhD, Postdoctoral Fellow, University of Colorado at Denver, for his project “The Role, Relationship and Therapeutic Potential of HAS2 and AGL in.” Dr. Guin will be investigating a novel signaling pathway and potential drug-able target for formation, aggressiveness, and .
A JPB FOUNDATION YOUNG INVESTIGATOR AWARD was granted to Ryoichi Saito, MD, PhD, Research Associate, University of North Carolina at Chapel Hill, for his project, “Consequences of ARID1A Inactivation in.” Dr. Saito will be expanding the findings from The Cancer Genome Atlas Project in , specifically focusing on a mutated in one of the most frequently altered pathways to better characterize its mechanism in development. He will also be developing a novel mouse model for .
A JPB FOUNDATION YOUNG INVESTIGATOR AWARD was also granted to Dmitriy Zamarin, MD, PhD, Hematology/Oncology Fellow, Memorial Sloan-Kettering Cancer Center, for his project “DefiningTargets in Microenvironment Using Oncolytic Viruses.” Dr. Zamarin is examining using an oncolytic virus to activate the immune system to recognize cancer cells, and combined with other immunotherapies to combat metastatic . Dr. Zamarin will also work on identifying immune resistance mechanisms in .
To learn more about BCAN’s research and the young investigators program, go to http://www.bcan.org/research/grants/.